Personalised Medicine : A New Form Of Cancer Treatment

Personalized medicine is currently on the running towards becoming one of the leading advancing fields of health care determined by a person’s individual genetic make-up. It enables an understanding of the molecular framework of the human system so as to augment preventive therapeutic strategies. The move from reactive to preventive health care comes about with the implementation of personalized medicine as an alternative to traditional health care practices.

The same translational barriers that apply to clinical research more generally apply to personalized medicine in particular. Discoveries in the lab still take years to be widely adopted in practice. One stepping stone to truly personalized medicine that arguably has been achieved, and continues to evolve, is genomic medicine, also called stratified medicine (Trusheim et al 2007; Ginsburg and Willard 2009). Stratified medicine involves clinical are that is based on specific qualities of an individual, often derived from molecular fingerprints. Subjects may be divided into different classes based on their genetics or some other high dimensional omicscale biomarker. Fig 25.3. This classification can then be used to guide clinical decision making.

HC2: With personalized medicine comes many areas of concern, including cost and ethics. It is well known that medical testing of any kind is typically very costly, and personalized medicine is no different. Medical institutions are often slow to adopt new technology and unwilling

Personalized medicine can lead to the development of great discoveries that could revolutionize the world. The research of personalized medicine is new and costly but that is not the only setback this new science must face. Personalized medicine has also presented issues of race and gender that cannot be silenced until further research is conducted. It is clear that personalized medicine could provide great benefits for fighting illness, but it can lead to issues of underrepresentation of race and concerns of gender in terms of drug safety and with the little that is known right now the cost outweigh the benefits.

Some of traditional drugs may be effective in patients whose cancers have a specific molecular target, and not for other patients. To solve this problem of patient-specificity, pharmaceutical research have seen the expansion of individually tailored cancer treatment, which is an application of targeted therapy, and this is where biopharmaceuticals are. As an increasing part of the population is diagnosed with cancer and as these patients live longer, increasing care will be given to patients who have received these drugs. Moreover, in the case of cancer therapy, those drugs and especially with mABs are a promise of less side effects : recombinant DNA technology makes it possible to genetically engineer an antibody to reduce the risk of host immune response.

For many types of cancers, we have been using the same base drug (first line treatment) for ten years or even longer. As companies find new drugs to fight the cancers, they hope that it will be the miracle drug that will eradicate the cancer, but it usually isn’t. When they reach this conclusion, instead of returning to the chalkboard and continuing to work to improve the drug, they put the drug on the market as is, and hope it will achieve something. Not only are they putting these drugs on the market but they put price tags on them that would bankrupt anyone without some sort of third party payer. The combination of all of these drugs make up what doctors

Abstract Cancer “Sucks” and many individuals today are dealing with it or know someone who has dealt with it. The late president Richard Nixon declared war on cancer in 1971 and we have been fighting the battle ever since (McCarthy, 2015, paras. 16). Since the declaration many possible cures were developed and chemotherapy is the one which seems to work on almost every cancer. However, this treatment has drawbacks that are either controversial or questionable as to what degree they help with defeating cancer.

Personalized medicine is the novel medicine of the millennium where medicine used is determined via a person’s genetic makeup and how the tumor grows using personalized medicine. Personalized cancer treatments hold great promises as it involves selection of treatments based on a person’s unique genetic makeup and the genetic makeup of the tumor. Nowadays, a person receives a standard treatment plan with specific personalized cancer treatments which tailors for the right cancers.

The book The Personalized Medicine Revolution: How Diagnosing and Treating Disease are About to Change Forever is an interesting journey through the evolution of our scientific knowledge and subsequent technologies followed by a final foray into the most current accomplishments in personalized medicine and where it’s going.

As the cancer continues to spread throughout society, many treatments are creating in order to help the patients during their time in need. Although the most popular and used often

Cancer is figured to be the second leading causes of morbidity and mortality worldwide. With approximately 14 million new cases and 8.2 million cancer related deaths in 2012, alone .Why are so many people stuck suffering with this deadly disease? Millions of dollars have been invested into cancer research, yet there is no cure. Are these pharmaceutical companies focus on finding a cure for cancer or concentrating on elongated treatments in order to lengthen their pockets? We must first understand that cancer is big business earning huge profits. Nonetheless, the cancer industry is spending virtually zilch of its multi-billion dollar resources on effective prevention strategies, like dietary guidelines, exercise, natural remedies and herbs proven to cure cancer. Instead, it pours its money into treating cancer, not preventing or allaying it.

Cancer. We all know someone who has suffered from it or has passed away because of it. Cancer now affects one in every three people, and is the second highest cause of death in the United States. For decades, the medical community has been on the hunt for a cure for cancer, and have been subjected to intense ridicule from the public because of a lack of progression toward a possible cure. In recent years, many scientists, doctors, researchers, and the general public have come to believe that the cure for cancer is being suppressed because of this lack of progress. Those who say it is suppressed claim that the drugs used to treat cancer actually cause cancer, making a patient sicker and sicker. As a result, the patients are forced to spend

One of the very last words anyone wants to hear from their doctors or loved ones is cancer. The word automatically instills fear, confusion, denial, and leaves the individual questioning his or her beliefs wondering “Why me?”. It overpowers all previous commitments or opportunities seizing control over the customary quality of life. Cancer is a disease caused by an uncontrolled division of abnormal cells in a part of the body often metastasizing elsewhere. With more than two hundred types of cancer that can affect more than sixty organs, cancer kills a half million people annually in the United States alone1. It is understandable why cancer’s reputation is dismal and menacing. Although there is no cure for cancer, doctors and researchers

As our world progresses, new technological inventions are being created to help better and improve the state of not just our environment but us as individuals. As an engineer, my job is to not only envision the next big change to lives in healthcare but to also to start engineering them. These technological advancements could be creating a personalized medicine for people that need it and in by doing so, would serve the exact purpose for the individual to which it was designed for.

Today we have more knowledge and awareness than ever of the genetic variants driving most diseases, such as cancer, asthma and heart disease (Fagan, 2016). This knowledge is resulting in a move to a more personalised approach (2016) to healthcare. The shift to personalised medicine and healthcare will likely have a significant impact on the modern pharmaceutical industry.